Crossmark

Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia

Crossref DOI link: https://doi.org/10.1016/j.medcle.2020.07.014

Published Print: 2020-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ulhaq, Zulvikar Syambani

Soraya, Gita Vita
License Information

Text and Data Mining valid from 2020-12-01
More Information

This article is maintained by: Elsevier

Article Title: Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2020.07.014

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2020.07.002

Content Type: article

Copyright: © 2020 Elsevier España, S.L.U. All rights reserved.